Skip to content

Public FDA record

Z-1219-2019: CryoPatch SG Pulmonary Hemi-Artery Patch

Recall record Z-1219-2019 for CryoLife, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1219-2019
Company in FDA record
CryoLife, Inc.
FDA record creation date
Apr 25, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The device is recalled due to donor ineligibility of released human tissue. The firm received information that the tissue donor's blood culture tested positive for Enterobacter cloacae.

Source facts

Action
The firm sent the physician a letter on 11/21/2016.
Initiated
2016-11-21
Root cause
Release of Material/Component prior to receiving test results
Terminated
2019-09-24
Distribution
Product was shipped to Texas
Recall number
Z-1219-2019
Recall status
Terminated
CDRH record ID
171642
FDA record created
2019-04-25
Recall event number
82380

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗